Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AMGN | GILD | CELG | ILMN |
| Company | Apellis Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 50.00 | 265.72 | 65.50 | 108.01 | 119.65 |
| High | 50.83 | 271.68 | 66.35 | 108.59 | 123.73 |
| Low | 48.85 | 265.72 | 64.63 | 107.27 | 118.97 |
| Last | 50.71 | 270.32 | 65.48 | 108.24 | 123.07 |
| Change | +2.78 | +0.94 | +0.21 | +0.11 | +2.02 |
| % Change | +5.80% | +0.35% | +0.32% | +0.10% | +1.67% |
| Volume | 502,842 | 643,821 | 6,804,694 | 191,230,496 | 298,706 |
| 20-Day Average Volume | 1,170,541 | 2,064,327 | 6,766,125 | 16,188,930 | 1,484,077 |
| Previous Close | 47.93 | 269.38 | 65.27 | 108.13 | 121.05 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 52.43 | 269.99 | 68.30 | 108.17 | 124.93 |
| 20-Day Raw Stochastic | 29.83% | 40.16% | 11.64% | 63.25% | 33.86% |
| 20-Day Relative Strength | 41.82% | 45.50% | 30.43% | 64.69% | 44.90% |
| Weighted Alpha | -6.63 | +9.47 | -23.14 | +46.30 | -36.88 |
| Today's Opinion | 40% Sell | 56% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 40% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 8% Buy | 40% Buy | 88% Sell | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.10% since 04/19/24 | +0.40% since 04/19/24 | -1.69% since 04/19/24 | -1.97% since 11/13/19 | +5.13% since 04/19/24 |
| Low | 46.63 on 04/22/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 116.91 on 04/25/24 |
| High | 50.83 on 04/26/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | -14.53% since 03/26/24 | -4.17% since 03/26/24 | -9.36% since 03/26/24 | +5.14% since 10/18/19 | -7.74% since 03/26/24 |
| Low | 46.40 on 04/18/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 59.91 on 04/01/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | -21.25% since 01/26/24 | -13.39% since 01/26/24 | -17.47% since 01/26/24 | +13.63% since 08/20/19 | -12.22% since 01/26/24 |
| Low | 46.40 on 04/18/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 71.90 on 02/26/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +4.09% since 10/26/23 | +0.11% since 10/26/23 | -16.39% since 10/26/23 | +14.14% since 05/20/19 | +10.59% since 10/26/23 |
| Low | 41.19 on 11/06/23 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 73.80 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,779,496 | 144,488,960 | 81,266,176 | 77,035,920 | 19,277,818 |
| Shares Outstanding, K | 120,582 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 396,590,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -528,630,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 146,380,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -88,580,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.88 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 02/27/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 141.23 |